Effect of an Internet Based Compliance Enhancement Tool in Subjects With Hypercholesterolemia

Clinical trial NCT00240357 · WITHDRAWN

Trial details

NCT number: NCT00240357
Sponsor: AstraZeneca
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

Hypercholesterolemia

Start date: 2003-02-01
Enrollment: 1175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.